PPMD Community

All Blog Posts Tagged 'Staff' (513)


Staff
November 24: FDA Advisory Committee Meeting - Live Webcast Information

Tomorrow, November 24, 2015, is a historic day for the Duchenne community as we enter into our first Advisory Committee Meeting with the FDA. While some of you may be attending in person or even participating, we know that many of you are curious as to how the process will unfold…

Continue

Added by PPMD on November 23, 2015 at 2:00pm — No Comments


Staff
PTC Thanks the Duchenne Community

Dr. Stu Peltz from PTC Therapeutics shares his gratitude to the Duchenne community for the contribution families have made to the development of their therapy, Translarna.

Read Dr. Peltz's…

Continue

Added by PPMD on November 18, 2015 at 3:00pm — No Comments


Staff
The Big Day is Almost Here!

For those of us who’ve been in this community for decades, at some point we began to believe that we’d never see the day when products that had been designed specifically with the intent to treat individuals with Duchenne would be…

Continue

Added by Annie Kennedy on November 18, 2015 at 11:00am — No Comments


Staff
FDA Advisory Committee Scenarios

By now, you probably know what to expect from the upcoming Advisory Committee meetings in terms of logistics: how to submit written testimony, how to apply for an open public hearing slot, order of the day, etc. (…

Continue

Added by PPMD on November 17, 2015 at 1:00pm — No Comments


Staff
PPMD Supports Advancing Targeted Therapies for Rare Diseases Act of 2015 (S. 2030)

For over a year, PPMD has been working with congressional champions and industry partners to help lead an effort to streamlining the regulatory pathways and review processes for targeted therapeutics (which would include such things as 'follow on exons') by clarifying the FDA’s existing…

Continue

Added by PPMD on November 12, 2015 at 1:09pm — 1 Comment


Staff
Help Us Protect Your Wheelchair Technology Access – Act Now to Close a CMS Loophole!

Many of you have seen – and signed – a petition that circulated recently about preventing Medicare from applying competitive bidding prices to complex technology; an action that will likely reduce access to wheelchair features many of our family members depend on. This effort has now evolved into a legislative effort and we urge all members of our…

Continue

Added by Annie Kennedy on November 3, 2015 at 10:00am — No Comments

A Paradigm Shift in Drug Discovery

Last week I participated in a briefing for Congressional staff in honor of the 10th anniversary of the founding of the Critical Path Institute, our partner in the…

Continue

Added by John D. Porter, PhD on October 27, 2015 at 10:50am — 4 Comments


Staff
PPMD Submits Results of Patient-Centered Benefit-Risk Assessment Study in Duchenne & Becker to FDA

PPMD is pleased to announce that late yesterday we submitted the results of our most recent patient-centered benefit-risk assessment (PCBR) study to the FDA. The assessment was done with research partners at the Johns Hopkins Bloomberg School…

Continue

Added by PPMD on October 22, 2015 at 7:48am — No Comments


Staff
Details & Guidance on Submitting Written Testimony to the FDA Advisory Committee

Why Are Written Comments Important? How Are They Utilized?

Written comments are compiled and shared with the FDA Advisory Committee members prior to the date of a product’s/ company’s Advisory Committee meeting. Thus, written comments are a…

Continue

Added by PPMD on October 20, 2015 at 3:30pm — No Comments


Staff
Ad Comms Update: Group Letter Submitted to FDA

PPMD is proud to help author and share the attached letter to Dr. Janet Woodcock, Director of the…

Continue

Added by PPMD on October 19, 2015 at 11:00am — No Comments

Annual Meeting: Patient-Centered Outcomes Research Institute (PCORI)

The first annual meeting of PCORI was held in Washington, DC on October 6-8.  1,100 researchers, patients, caregivers, health system and industry representatives, and others were present to hear updates on patient-centered comparative clinical effectiveness research.  PCORnet is a “network of…

Continue

Added by John D. Porter, PhD on October 16, 2015 at 1:07pm — No Comments


Staff
2015 Flu Vaccination Recommendations

It’s fall, so it must be time for my annual mantra – Get Your Flu Vaccine!!

 

Everyone, 6 months of age and older, needs to be vaccinated against influenza, and protecting children with neuromuscular disease is especially important. A…

Continue

Added by Kathi Kinnett on October 16, 2015 at 1:00pm — No Comments

Preclinical Studies with Simvastatin in the Mdx Mouse Model of Duchenne

Stan Froehner’s group at the University of Washington recently reported preclinical efficacy data on the approved drug, Simvastatin, in the mdx mouse model of Duchenne (see…

Continue

Added by John D. Porter, PhD on October 16, 2015 at 11:30am — No Comments


Staff
Ad Comms Update: Defining Unmet Medical Need

After yesterday’s news regarding the Ad Comms for both BioMarin and Sarepta, the community continues to ask questions. PPMD has been working around the clock to get some answers…

Continue

Added by Pat Furlong on October 15, 2015 at 3:30pm — No Comments


Staff
Ad Comms Update: An Overwhelming Day

Today we learned that the FDA will host an Advisory Committee (Ad Comm) meeting on November 24 to discuss the…

Continue

Added by Pat Furlong on October 14, 2015 at 4:30pm — No Comments


Staff
PPMD’s PRO Project: Adding more tools to help with upcoming clinical trials in Duchenne

What’s a PRO?

Several patient-report outcomes (PROs) have been validated for use in people with Duchenne and their caregivers. Patient-report outcomes are a way for patients and families to provide structured input about their own…

Continue

Added by PPMD on October 13, 2015 at 11:30am — No Comments


Staff
PPMD Urges Senate to Move Forward on #Cures2015 Innovation for Healthier Americans Bill

Yesterday, I had the distinct privilege of representing PPMD and our Duchenne community as I sat before a full room of Senate staffers and congressional aides in the Dirksen Senate office building. Our goal was to urge them to press forward on the Innovation for Healthier Americans bill (also referred to as the ‘Innovation…

Continue

Added by Annie Kennedy on October 9, 2015 at 12:00pm — 1 Comment


Staff
Industry partners receive FDA’s Pediatric Rare Disease Designation – and YOU helped make it possible!

In the last few weeks we’ve heard the news from several companies working to develop therapies for Duchenne that they have received Rare Pediatric Disease Designations from the FDA. Santhera, Sarepta, Catabasis, and Biomarin.

 

We as a community have celebrated this news. But…

Continue

Added by Annie Kennedy on October 7, 2015 at 4:30pm — No Comments


Staff
News from 2015 World Muscle Society: Days 3-4

This is our final update from the 2015 World Muscle Society meeting in Brighton, United Kingdom (click here for updates from previous days). Before providing summaries of some presentations on the…

Continue

Added by PPMD on October 6, 2015 at 10:30am — No Comments


Staff
News from 2015 World Muscle Society: Days 2-3

Dr. John Porter and Kathi Kinnett from the PPMD team…

Continue

Added by PPMD on October 5, 2015 at 10:23am — No Comments

Monthly Archives

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Need help using this community site? Visit Ning's Help Page.

© 2016   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service